Role of protein kinase C in arginine vasopressin-stimulated ERK and p70S6 kinase phosphorylation

Journal of Cellular Biochemistry

Volumn 91, Issue 6, 2004, Pages 1109-1129

  Ghosh, Paramita M ^a   Bedolla, Roble ^a   Thomas, Charles A ^b   Kreisberg, Jeffrey I ^a,c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

EGF R; PI3K; Proliferation

Indexed keywords

ARGIPRESSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; S6 KINASE; SERINE; THREONINE; ENZYME INHIBITOR; ISOENZYME; URINARY TRACT AGENT;

ARTICLE; CELL PROLIFERATION; GLOMERULUS; MESANGIUM CELL; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; MESANGIUM; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ARGININE VASOPRESSIN; CELL DIVISION; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME INHIBITORS; GLOMERULAR MESANGIUM; ISOENZYMES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RENAL AGENTS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION;

EID: 7444248949     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.10789     Document Type: Article

References (67)

1. Akimoto K, Takahashi R, Moriya S, Nishioka N, Takayanagi J, Kimura K, Fukui Y, Osada S, Mizuno K, Hirai S, Kazlauskas A, Ohno S. 1996. EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase. EMBO J 15:788-798.
2. Alessi DR, Kozlowski MT, Weng QP, Morrice N, Avruch J. 1998. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol 8:69-81.
3. Bao J, Alroy I, Waterman H, Schejter ED, Brodie C, Gruenberg J, Yarden Y. 2000. Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome. J Biol Chem 275:26178-26186.
4. Bonventre JV, Skorecki KL, Kreisberg JI, Cheung JY. 1986. Vasopressin increases cytosolic free calcium concentration in glomerular mesangial cells. Am J Physiol 251:F94-F102.
5. Bornancin F, Parker PJ. 1996. Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Calpha. Curr Biol 6:1114-1123.
6. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD. 1991. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675.
7. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S. 1991. Oncogenes and signal transduction. Cell 64:281-302.
8. Carpenter G, Ji Q. 1999. Phospholipase C-gamma as a signal-transducing element. Exp Cell Res 253:15-24.
9. Carpenter CL, Auger KR, Duckworth BC, Hou WM, Schaffhausen B, Cantley LC. 1993. A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol Cell Biol 13:1657-1665.
10. Cenni V, Doppler H, Sonnenburg ED, Maraldi N, Newton AC, Toker A. 2002. Regulation of novel protein kinase C epsilon by phosphorylation. Biochem J 363: 537-545.
11. Chandrasekher G, Kakazu AH, Bazan HE. 2001. HGF- and KGF-induced activation of PI-3K/p70 s6 kinase pathway in corneal epithelial cells: Its relevance in wound healing. Exp Eye Res 73:191-202.
12. Chardonnens D, Lang U, Capponi AM, Vallotton MB. 1989. Comparison of the effects of angiotensin II and vasopressin on cytosolic free calcium concentration, protein kinase C activity, and prostacyclin production in cultured rat aortic and mesenteric smooth muscle cells. J Cardiovasc Pharmacol 14(Suppl 6):S39-S44.
13. Chou MM, Hou W, Johnson J, Graham LK, Lee MH, Chen CS, Newton AC, Schaffhausen BS, Toker A. 1998. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr Biol 8:1069-1077.
14. Corbit KC, Soh JW, Yoshida K, Eves EM, Weinstein IB, Rosner MR. 2000. Different protein kinase C isoforms determine growth factor specificity in neuronal cells. Mol Cell Biol 20:5392-5403.
15. Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, Gout I, Totty NF, Truong O, Vicendo P, Yonezawa K, et al. 1994. PI 3-kinase is a dual specificity enzyme: Autoregulation by an intrinsic protein-serine kinase activity. EMBO J 13:522-533.
16. Dufner A, Thomas G. 1999. Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 253:100-109.
17. Dutil EM, Keranen LM, DePaoli-Roach AA, Newton AC. 1994. In vivo regulation of protein kinase C by trans-phosphorylation followed by autophosphorylation. J Biol Chem 269:29359-29362.
18. Dutil EM, Toker A, Newton AC. 1998. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr Biol 8:1366-1375.
19. Egan JJ, Saltis J, Wek SA, Simpson IA, Londos C. 1990. Insulin, oxytocin, and vasopressin stimulate protein kinase C activity in adipocyte plasma membranes. Proc Natl Acad Sci USA 87:1052-1056.
20. Foschi M, Chari S, Dunn MJ, Sorokin A. 1997. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase. EMBO J 16:6439-6451.
21. Ganz MB, Pekar SK, Perfetto MC, Sterzel RB. 1988. Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture. Am J Physiol 255:F898-F906.
22. 2+. Am J Physiol 259:F269-F278.
23. Gao Y, Tang S, Zhou S, Ware JA. 2001. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J Pharmacol Exp Ther 296:426-433.
24. Ghosh PM, Mikhailova M, Bedolla R, Kreisberg JI. 2001. Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor. Am J Physiol Renal Physiol 280:F972-F979.
25. Gliki G, Wheeler-Jones C, Zachary I. 2002. Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3′-kinase-mediates PKC delta phosphorylation: Role of PKC in angiogenesis. Cell Biol Int 26:751-759.
26. Grewe M, Gansauge F, Schmid RM, Adler G, Seufferlein T. 1999. Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells. Cancer Res 59:3581-3587.
27. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F. 1994. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98.
28. Huwiler A, Schulze-Lohoff E, Fabbro D, Pfeilschifter J. 1993. Immunocharacterization of protein kinase C isoenzymes in rat kidney glomeruli, and cultured glomerular epithelial and mesangial cells. Exp Nephrol 1: 19-25.
29. Jard S, Lombard C, Marie J, Devilliers G. 1987. Vasopressin receptors from cultured mesangial cells resemble V1a type. Am J Physiol 253:F41-F49.
30. Johnson JA, Gray MO, Chen CH, Mochly-Rosen D. 1996. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 271: 24962-24966.
31. Johnson JA, Gray MO, Karliner JS, Chen CH, Mochly-Rosen D. 1996. An improved permeabilization protocol for the introduction of peptides into cardiac myocytes. Application to protein kinase C research. Circ Res 79: 1086-1099.
32. Kapeller R, Cantley LC. 1994. Phosphatidylinositol 3-kinase. Bioessays 16:565-576.
33. Keranen LM, Dutil EM, Newton AC. 1995. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr Biol 5:1394-1403.
34. Kikkawa R, Haneda M, Uzu T, Koya D, Sugimoto T, Shigeta Y. 1994. Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 37: 838-841.
35. Kim S, Jung Y, Kim D, Koh H, Chung J. 2000. Extracellular zinc activates p70 S6 kinase through the phosphatidylinositol 3-kinase signaling pathway. J Biol Chem 275: 25979-25984.
36. Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y. 1980. Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255:2273-2276.
37. Klippel A, Escobedo MA, Wachowicz MS, Apell G, Brown TW, Giedlin MA, Kavanaugh WM, Williams LT. 1998. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol 18:5699-5711.
38. Kreisberg JI, Wilson PD. 1988. Renal cell culture. J Electron Microsc Tech 9:235-263.
39. Kreisberg JI, Garoni JA, Radnik R, Ayo SH. 1994. High glucose and TGF beta 1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int 46:1019-1024.
40. Kreisberg JI, Radnik RA, Kreisberg SH. 1996. Phosphorylation of cAMP responsive element binding protein after treatment of mesangial cells with high glucose plus TGF beta or PMA. Kidney Int 50:805-810.
41. Kribben A, Wieder ED, Li X, van Putten V, Granot Y, Schrier RW, Nemenoff RA. 1993. AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C. Am J Physiol 265: C939-C945.
42. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042-2045.
43. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194-9197.
44. Moriya S, Kazlauskas A, Akimoto K, Hirai S, Mizuno K, Takenawa T, Fukui Y, Watanabe Y, Ozaki S, Ohno S. 1996. Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 93:151-155.
45. Newton AC. 1997. Regulation of protein kinase C. Curr Opin Cell Biol 9:161-167.
46. Newton AC. 2003. Regulation of the ABC kinases by phosphorylation: Protein kinase C as a paradigm. Biochem J 370:361-371.
47. Nishikawa T, Masao O, Iizuka T, Saito I, Yoshida S. 1996. Short-term clinical trial of 1-{1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl}-3,4- dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in patients with non insulin dependent diabetes mellitus. Arzneim Forsch/ Drug Res 46:875-878.
48. Nishizuka Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496.
49. Parekh DB, Ziegler W, Parker PJ. 2000. Multiple pathways control protein kinase C phosphorylation. EMBO J 19: 496-503.
50. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527-532.
51. Romanelli A, Martin KA, Toker A, Blenis J. 1999. p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol Cell Biol 19:2921-2928.
52. Rupprecht HD, Sukhatme VP, Rupprecht AP, Sterzel RB, Coleman DL. 1994. Serum response elements mediate protein kinase C dependent transcriptional induction of early growth response gene-1 by arginine vasopressin in rat mesangial cells. J Cell Physiol 159:311-323.
53. Saxena R, Saksa BA, Fields AP, Ganz MB. 1993. Activation of Na/H exchanger in mesangial cells is associated with translocation of PKC isoforms. Am J Physiol 265: F53-F60.
54. Schonwasser DC, Marais RM, Marshall CJ, Parker PJ. 1998. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18:790-798.
55. Schulze-Lohoff E, Kohler M, Fees H, Reindl N, Sterzel RB. 1993. Divergent effects of arginine vasopressin and angiotensin II on proliferation and expression of the immediate early genes c-fos, c-jun, and Egr-1 in cultured rat glomerular mesangial cells. J Hypertens 11: 127-134.
56. Selheim F, Holmsen H, Vassbotn FS. 2000. PI 3-kinase signalling in platelets: The significance of synergistic, autocrine stimulation. Platelets 11:69-82.
57. 2+ influx and diacylglycerol synthesis in growth hormone-mediated islet beta-cell mitogenesis. J Biol Chem 275:21033-21040.
58. Standaert ML, Bandyopadhyay G, Kanoh Y, Sajan MP, Farese RV. 2001. Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites. Biochemistry 40:249-255.
59. Summers ST, Bass BL. 1997. Protein kinase C inhibits epidermal growth factor receptor phosphorylation in enterocytes. J Surg Res 69:208-211.
60. Takai Y, Kishimoto A, Iwasa Y, Kawahara Y, Mori T, Nishizuka Y. 1979. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem 254:3692-3695.
61. Toker A, Meyer M, Reddy KK, Falck JR, Aneja R, Aneja S, Parra A, Burns DJ, Ballas LM, Cantley LC. 1994. Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3. J Biol Chem 269:32358-32367.
62. Troyer DA, Kreisberg JI, Schwertz DW, Venkatachalam MA. 1985. Effects of vasopressin on phosphoinositides and prostaglandin production in cultured mesangial cells. Am J Physiol 249:F139-F147.
63. Troyer DA, Gonzalez OF, Padilla RM, Kreisberg JI. 1992. Vasopressin and phorbol ester-stimulated phosphatidylcholine metabolism in mesangial cells. Am J Physiol 262:F185-F191.
64. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S. 1996. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271:23512-23519.
65. Venkatachalam MA, Kreisberg JI. 1985. Agonist-induced isotonic contraction of cultured mesangial cells after multiple passage. Am J Physiol 249:C48-C55.
66. Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2:489-501.
67. Vlahos CJ, Matter WF, Hui KY, Brown RF. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248.